Quick Comparison
| EGF (Epidermal Growth Factor) | Tretinoin | |
|---|---|---|
| Typical Concentration | Concentrations vary by product (typically measured in ppm or sh-oligopeptide-1 percentage). Applied once or twice daily. Best used after procedures or on aging skin. Apply before oils/occlusives. Store in refrigerator for stability. | Concentrations: 0.025%, 0.05%, 0.1%. Start with 0.025% every other night for 4-6 weeks, then increase frequency. Apply pea-sized amount to dry face 20 minutes after cleansing. Always use with SPF 30+ during the day. Retinization period: 4-12 weeks of initial irritation. |
| Application | Topical (serum, cream, ampoule). Apply to clean skin. Temperature-sensitive — some products require refrigeration. | Topical (cream, gel, microsphere). Apply to clean, dry skin at night. Microsphere formulations (Retin-A Micro) release tretinoin slowly, reducing irritation. |
| Research Papers | 10 papers | 10 papers |
| Categories |
Mechanism of Action
EGF (Epidermal Growth Factor)
EGF binds EGFR/ErbB1 on keratinocytes and fibroblasts, triggering dimerization and autophosphorylation. Activates MAPK/ERK (Ras-Raf-MEK-ERK) and PI3K/AKT pathways, promoting proliferation, migration (actin reorganization, focal adhesion turnover), and differentiation. Upregulates cyclin D1, inhibits p27. Stimulates fibroblast collagen types I/III and hyaluronic acid via HAS2. In wound healing, accelerates re-epithelialization via keratinocyte migration and reduces scarring via TGF-beta modulation. For anti-aging, promotes cellular renewal and extracellular matrix production. Theoretical cancer concern from EGFR's growth role — topical EGF has not been shown to penetrate to basal layer or systemic circulation significantly.
Tretinoin
Tretinoin binds nuclear retinoic acid receptors (RAR-alpha, beta, gamma), forming RAR/RXR heterodimers that bind retinoic acid response elements and activate gene transcription. This accelerates keratinocyte proliferation, reducing stratum corneum transit from ~28 to ~14 days. In the dermis, tretinoin stimulates fibroblasts and upregulates collagen I and III via TGF-beta while downregulating MMP-1, MMP-3, and MMP-9 that degrade the extracellular matrix. It normalizes melanocyte distribution and melanosome transfer. In acne, it prevents microcomedo formation by normalizing follicular keratinocyte differentiation and reducing corneocyte cohesion. RAR activation also modulates genes for epidermal growth factors and differentiation markers.
Risks & Safety
EGF (Epidermal Growth Factor)
Common
Very well-tolerated.
Serious
Theoretical concern about promoting growth of pre-existing skin cancers (unproven but debated).
Rare
Mild irritation.
Tretinoin
Common
Dryness, peeling, redness, increased sun sensitivity (mandatory SPF). Initial purging (breakouts) for 4-8 weeks.
Serious
Teratogenic — absolutely contraindicated in pregnancy and breastfeeding.
Rare
Severe irritant contact dermatitis, eczema flare-ups.
Full Profiles
EGF (Epidermal Growth Factor) →
A signaling protein that stimulates cell growth, proliferation, and differentiation. In skincare, EGF promotes wound healing, skin renewal, and collagen production. Originally used in medical wound care and post-laser recovery, it has become popular in Korean skincare for anti-aging. It is one of the few growth factors with evidence for topical skincare efficacy.
Tretinoin →
The gold standard anti-aging ingredient with the most clinical evidence of any topical. Tretinoin (all-trans retinoic acid) is the active form of vitamin A that directly binds to retinoic acid receptors in skin cells. It accelerates cell turnover, stimulates collagen synthesis, reduces fine lines and wrinkles, fades hyperpigmentation, and improves skin texture. Prescription-only in most countries.